These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8160247)
21. Comparison of analytical methods in the determination of two venlafaxine fatalities. Long C; Crifasi J; Maginn D; Graham M; Teas S J Anal Toxicol; 1997; 21(2):166-9. PubMed ID: 9083836 [TBL] [Abstract][Full Text] [Related]
22. Effect Of Chinese Herb Danzhi Xiaoyao Pills On Pharmacokinetics Of Venlafaxine In Beagles. Zhu YL; Li SL; Chen KL; Ma KP; Wu DQ; Qiu XJ Drug Des Devel Ther; 2019; 13():3343-3355. PubMed ID: 31571835 [TBL] [Abstract][Full Text] [Related]
23. Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry. Pandey A; Price A; Ayala-Lopez N; Garza KY; Marzinke MA; Knezevic CE J Pharm Biomed Anal; 2024 Jun; 243():116082. PubMed ID: 38461636 [TBL] [Abstract][Full Text] [Related]
24. Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma. Bhatt J; Jangid A; Venkatesh G; Subbaiah G; Singh S J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):75-81. PubMed ID: 16249126 [TBL] [Abstract][Full Text] [Related]
25. DETERMINATION OF VENLAFAXINE, VILAZODONE AND THEIR MAIN ACTIVE METABOLITES IN HUMAN SERUM BY HPLC-DAD AND HPLC-MS. Petruczynik A; Wroblewski K; Szultka-Mlynska M; Buszewsk B; Karakula-Juchnowicz H; Gajewski J; Morylowska-Topolska J; Waksmundzka-Hajnosi M Acta Pol Pharm; 2017 May; 74(3):765-775. PubMed ID: 29513945 [TBL] [Abstract][Full Text] [Related]
26. A simple HPLC method for the simultaneous determination of venlafaxine and its major metabolite O-desmethylvenlafaxine in human serum. Samanidou V; Nazyropoulou C; Kovatsi L Bioanalysis; 2011 Aug; 3(15):1713-8. PubMed ID: 21827270 [TBL] [Abstract][Full Text] [Related]
27. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue. Murrell MD; Cruz DA; Javors MA; Thompson PM J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274 [TBL] [Abstract][Full Text] [Related]
28. Time course of clinical response to venlafaxine: relevance of plasma level and chirality. Gex-Fabry M; Balant-Gorgia AE; Balant LP; Rudaz S; Veuthey JL; Bertschy G Eur J Clin Pharmacol; 2004 Feb; 59(12):883-91. PubMed ID: 14704834 [TBL] [Abstract][Full Text] [Related]
29. Stereoselective determination of venlafaxine and its three demethylated metabolites in human plasma and whole blood by liquid chromatography with electrospray tandem mass spectrometric detection and solid phase extraction. Kingbäck M; Josefsson M; Karlsson L; Ahlner J; Bengtsson F; Kugelberg FC; Carlsson B J Pharm Biomed Anal; 2010 Nov; 53(3):583-90. PubMed ID: 20435422 [TBL] [Abstract][Full Text] [Related]
30. Simultaneous quantitation of venlafaxine and its main metabolite, O-desmethylvenlafaxine, in human saliva by HPLC. Dziurkowska E; Wesolowski M J Sep Sci; 2013 Jun; 36(11):1726-33. PubMed ID: 23495235 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting. Reis M; Lundmark J; Björk H; Bengtsson F Ther Drug Monit; 2002 Aug; 24(4):545-53. PubMed ID: 12142641 [TBL] [Abstract][Full Text] [Related]
32. Hollow-fiber liquid-phase microextraction and chiral LC-MS/MS analysis of venlafaxine and its metabolites in plasma. da Fonseca P; Bonato PS Bioanalysis; 2013 Mar; 5(6):721-30. PubMed ID: 23484789 [TBL] [Abstract][Full Text] [Related]
33. Simultaneous separation and determination of process-related substances and degradation products of venlafaxine by reversed-phase HPLC. Nageswara Rao R; Narasa Raju A J Sep Sci; 2006 Dec; 29(18):2733-44. PubMed ID: 17305234 [TBL] [Abstract][Full Text] [Related]
34. High-performance liquid chromatographic method for the determination of eclanamine and its N-desmethyl and N,N-didesmethyl metabolites in urine. Lakings DB; Friis JM; Bruns MB J Chromatogr; 1988 Jun; 428(1):131-9. PubMed ID: 3170665 [TBL] [Abstract][Full Text] [Related]
35. Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation study. da Fonseca P; Bonato PS Anal Bioanal Chem; 2010 Jan; 396(2):817-24. PubMed ID: 19937433 [TBL] [Abstract][Full Text] [Related]
36. The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxine. Wang CP; Howell SR; Scatina J; Sisenwine SF Chirality; 1992; 4(2):84-90. PubMed ID: 1616828 [TBL] [Abstract][Full Text] [Related]
37. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection. Mandrioli R; Mercolini L; Cesta R; Fanali S; Amore M; Raggi MA J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):88-94. PubMed ID: 17581798 [TBL] [Abstract][Full Text] [Related]
38. Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants. Rúa-Gómez PC; Püttmann W Environ Sci Pollut Res Int; 2012 Mar; 19(3):689-99. PubMed ID: 21909967 [TBL] [Abstract][Full Text] [Related]
39. Use of vancomycin silica stationary phase in packed capillary electrochromatography. II. Enantiomer separation of venlafaxine and O-desmethylvenlafaxine in human plasma. Fanali S; Rudaz S; Veuthey JL; Desiderio C J Chromatogr A; 2001 Jun; 919(1):195-203. PubMed ID: 11459304 [TBL] [Abstract][Full Text] [Related]
40. Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. Qin F; Li N; Qin T; Zhang Y; Li F J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):689-94. PubMed ID: 20133212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]